DLL4, Human Antibody from MILTENYI BIOTEC B.V. & Co. KG

Search, find, compare suppliers for anti-DLL4, Human antibody, protein, ELISA kits.

Edit 
Antigenic SpecificityDLL4, Human
CloneREA1065
Host SpeciesRecombinant Human
Reactive Specieshuman
IsotypeIgG1
FormatVioGreen conjugate
Size100 tests in 200 µL
Concentration1:50
ApplicationsFlow cytometry
Reviews / RatingsIf you have used this antibody, please help fellow researchers by submitting reviews to pAbmAbs and antYbuddY.
DescriptionDLL4 Antibody, anti-human, VioGreen™, REAfinity™. Clone REA1065 recognizes the human delta-like4 (DLL4) antigen, which is a type I membrane protein belonging to the Delta/Serrate/Lag2 (DSL) family of Notch ligands. Notch signaling controls cell fate decisions and is involved in multiple developmental processes. Notch ligands are categorized into two subfamilies: the Jagged and the Delta ligand family. In mammals, five ligands (DLL 1, 3, and 4, Jagged 1 and 2) have been identified. DLL4 is highly expressed within vascular endothelial cells, thymic epithelial cells, and dendritic cell subsets and plays an important role for vascular development and homeostasis and thymic as well as peripheral T cell differentiation. | Additional information: Clone REA1065 displays negligible binding to Fc receptors.
Immunogenn/a
Other Nameshdelta2, Delta-like4, Delta-like protein 4
Gene, Accession #Gene ID: 54567
Catalog #130-118-228
Price$395
Order / More InfoDLL4, Human Antibody from MILTENYI BIOTEC B.V. & Co. KG
Product Specific ReferencesNoguera-Troise, I. et al. (2006) Blockade of Dll4 inhibits tumour growth by promoting non-productive angiogenesis. Nature 444 (7122): 1032-1037. | Ridgeway, J. et al. (2006) Inhibition of Dll4 signalling inhibits tumour growth by deregulating angiogenesis. Nature 444 (7122): 1083-1087. | Koch, U. et al. (2008) Delta-like 4 is the essential, nonredundant ligand for Notch1 during thymic T cell lineage commitment. J. Exp. Med. 205 (11): 2515-2523. | Hozumi, K. et al. (2008) Delta-like 4 is indispensable in thymic environment specific for T cell development. J. Exp. Med. 205 (11): 2507-2513. | Radtke, F. et al. (2010) Notch signaling in the immune system. Immunity 32: 14-27.
MILTENYI BIOTEC B.V. & Co. KG
MILTENYI BIOTEC B.V. & Co. KG
MILTENYI BIOTEC B.V. & Co. KG
Friedrich-Ebert-Straße 68
51429 Bergisch Gladbach GERMANY
P: +49 2204 8306-0
F: +49 2204 85197

macs@miltenyibiotec.de

https://www.miltenyibiotec.com

Profile of MILTENYI BIOTEC B.V. & Co. KG
Return to Antibodies

© 1980 - 2024 Linscott's Directory, Linscott's USA. All rights reserved.